What is C5 Acquisition Corporation (CXAC) stock price today?

C5 Acquisition Corporation (CXAC) is currently trading at $10.79, up 0.42% today.

What is CXAC P/E ratio?

C5 Acquisition Corporation's P/E ratio is 198.25. This is above the market average, reflecting high growth expectations.

What is CXAC return on equity (ROE)?

C5 Acquisition Corporation's return on equity (ROE) is 1.05%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is C5 Acquisition Corporation's market cap?

C5 Acquisition Corporation has a market capitalization of $387.59M.

NYSE · Shell Companies

C5 Acquisition Corporation (CXAC) Stock

$10.79 +0.42% NYSE: CXAC Financial Services

C5 Acquisition Corporation currently conducts no major business operations. Its core objective is to execute a strategic union, such as a merger, consolidation, equity exchange, asset purchase, stock acquisition, reorganization, or a comparable business integration, with one or more entities.

Valuation

Metric	Value
Price	$10.79
Market Cap	$387.59M
P/E Ratio	198.25
P/B Ratio	1.05
P/S Ratio	0.00
EPS (TTM)	$0.05
52-Week High	$11.85
52-Week Low	$10.05
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	1.05%
ROA	0.51%
ROCE	-2.05%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.00
Current Ratio	1.28

Annual Financials (USD)

Metric	2021	2022
Revenue	$0	$0
Operating Profit	$0	$-6.0M
Net Profit	$0	$2.0M
EPS	$0.00	$0.05
Op Margin	—	—

Balance Sheet (USD)

Metric	2021	2022
Total Assets	$1.0M	$299.0M
Total Liabilities	$1.0M	$11.0M
Cash	$0	$1.0M
Borrowings	$0	$0

Latest News

Renault says sales stalled in first half AFP · Jul 23, 2026 Should You Buy Amazon and Meta Platforms Stocks Before July 29? Motley Fool · Jul 23, 2026 Lundbeck receives FDA Fast Track designation for Lu AH69593, an investigational orexin 2 receptor agonist for narcolepsy PR Newswire · Jul 23, 2026 Why Gartner Stock Swooned in the First Half of 2026 Motley Fool · Jul 23, 2026 1 Industrials Stock with Exciting Potential and 2 We Find Risky StockStory · Jul 23, 2026

Cash Flow (USD)

Metric	2021	2022
Operating Cash Flow	$0	$-2.0M
Investing Cash Flow	$0	$-293.0M
Financing Cash Flow	$0	$296.0M
Net Cash Flow	$0	$1.0M
Free Cash Flow	$0	$-2.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.76
EV / EBITDA	-63.40
FCF Yield	-0.54%
Quick Ratio	1.28
Interest Coverage	0.00
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AHRNAhren Acquisition Corp.	$10.49	+0.00%	2.50	$393.38M	0.00%
APGBApollo Strategic Growth Capital II	$10.59	+0.06%	13.23	$372.23M	0.00%
CHAACatcha Investment Corp	$8.90	+7.23%	-18.94	$77.57M	0.00%
ESMESM Acquisition Corporation	$10.20	-0.05%	68.00	$391.35M	0.00%
LCAAL Catterton Asia Acquisition Corporation	$13.51	+2.43%	1608.33	$391.06M	0.00%

About C5 Acquisition Corporation

C5 Acquisition Corporation is headquartered in US.

C5 Acquisition Corporation (CXAC) stock trades at $10.79 with a market capitalization of $387.59M. The stock is valued at a price-to-earnings (P/E) ratio of 198.25, price-to-book of 1.05, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $10.05 and $11.85, and currently trades 8.9% below its 52-week high.

On profitability, C5 Acquisition Corporation generates a return on equity (ROE) of 1.05%, return on capital employed of -2.05%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: c5acquisitions.com